LUCAT1 and triple-negative breast carcinoma: LUCAT1 is upregulated in breast cancer, including triple-negative breast cancer, where it promotes tumor progression and is linked to poor prognosis (16).Numerous studies have demonstrated that suppression of LUCAT1 expression can inhibit the advancement of breast cancer,indicating it as a novel therapy target.